These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 11113052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure.
    Chen Y, Traverse JH, Hou M, Li Y, Du R, Bache RJ.
    Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1513-20. PubMed ID: 12679324
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig.
    Kruuse C, Khurana TS, Rybalkin SD, Birk S, Engel U, Edvinsson L, Olesen J.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):105-14. PubMed ID: 16182282
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overall cardiovascular profile of sildenafil citrate.
    Zusman RM, Morales A, Glasser DB, Osterloh IH.
    Am J Cardiol; 1999 Mar 04; 83(5A):35C-44C. PubMed ID: 10078541
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclic GMP phosphodiesterase-5: target of sildenafil.
    Corbin JD, Francis SH.
    J Biol Chem; 1999 May 14; 274(20):13729-32. PubMed ID: 10318772
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE, Yugar-Toledo JC, Coelho OR, De Luca IM, Tanus-Santos JE, Hyslop S, Irigoyen MC, Moreno H.
    Eur J Pharmacol; 2006 Aug 07; 542(1-3):141-7. PubMed ID: 16806160
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels.
    Medina P, Segarra G, Martínez-León JB, Vila JM, Aldasoro M, Otero E, Lluch S.
    Ann Thorac Surg; 2000 Oct 07; 70(4):1327-31. PubMed ID: 11081893
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
    Yuan Z, Hein TW, Rosa RH, Kuo L.
    Invest Ophthalmol Vis Sci; 2008 Feb 07; 49(2):720-5. PubMed ID: 18235020
    [Abstract] [Full Text] [Related]

  • 18. The potential use of type-5 phosphodiesterase inhibitors in coronary artery bypass graft surgery.
    Fung E, Fiscus RR, Yim AP, Angelini GD, Arifi AA.
    Chest; 2005 Oct 07; 128(4):3065-73. PubMed ID: 16236987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sildenafil in patients with cardiovascular disease.
    Brindis RG, Kloner RA.
    Am J Cardiol; 2003 Nov 06; 92(9A):26M-36M. PubMed ID: 14609621
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.